16.50
Uniqure N V Borsa (QURE) Ultime notizie
uniQure Announces Completion of Enrollment in the First - GlobeNewswire
UniQure Advances AMT-191 Trial in Fabry Disease -February 03, 2025 at 12:09 pm EST - Marketscreener.com
uniQure advances gene therapy trial for Fabry disease By Investing.com - Investing.com Australia
uniQure advances gene therapy trial for Fabry disease - Investing.com
Rare Disease Breakthrough: Gene Therapy Trial Shows Promise in Fabry Disease Treatment - StockTitan
HC Wainwright Issues Negative Estimate for uniQure Earnings - MarketBeat
Analysts Set Expectations for uniQure FY2029 Earnings - MarketBeat
uniQure (NASDAQ:QURE) Trading Down 4.8%Should You Sell? - MarketBeat
(QURE) Proactive Strategies - Stock Traders Daily
uniQure Announces Favorable Recommendation from Independent - GlobeNewswire
UniQure Gets Favorable Recommendation From Data Monitoring Committee AMT-162 Trial to Treat Amyotrophic Lateral Sclerosis - Marketscreener.com
uniQure Announces Favorable Recommendation from Independent Data Monitoring Committee for its Phase I/II EPISOD1 Clinical Trial of AMT-162 for the Treatment of SOD1-ALS - The Manila Times
Game-Changing ALS Treatment: uniQure's Gene Therapy Hits Critical Milestone - StockTitan
H.C. Wainwright sets uniQure stock price target at $70 By Investing.com - Investing.com Australia
The Hidden Gem in Biotechnology? It’s Time to Take Notice - Jomfruland.net
Is uniQure N.V. (QURE) the Most Promising Growth Stock According to Wall Street Analysts? - Insider Monkey
H.C. Wainwright sets uniQure stock price target at $70 - Investing.com India
uniQure (NASDAQ:QURE) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
12 Most Promising Growth Stocks According to Wall Street Analysts - Insider Monkey
Assenagon Asset Management S.A. Sells 197,775 Shares of uniQure (NASDAQ:QURE) - MarketBeat
Brokers Offer Predictions for uniQure FY2025 Earnings - MarketBeat
JPMorgan Chase & Co. Sells 270,042 Shares of uniQure (NASDAQ:QURE) - MarketBeat
uniQure (QURE) Stock Price, News & Analysis - MarketBeat
Royal Bank of Canada Reaffirms Outperform Rating for uniQure (NASDAQ:QURE) - MarketBeat
(QURE) Technical Pivots with Risk Controls - Stock Traders Daily
Hemophilia B Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharma, CSL Behring, uniQure, Novo Nordisk - The Globe and Mail
Sanders Morris Harris LLC Increases Stake in uniQure (NASDAQ:QURE) - MarketBeat
Here’s Why uniQure N.V. (QURE) Is Skyrocketing - MSN
Short Interest in uniQure (NASDAQ:QURE) Declines By 21.2% - MarketBeat
Why These 24 Stocks Are Skyrocketing - Insider Monkey
12 Best Growth Stocks to Buy and Hold in 2025 - Insider Monkey
Is uniQure N.V. (QURE) Among the Best Growth Stocks to Buy and Hold in 2025? - Insider Monkey
(QURE) Trading Signals - Stock Traders Daily
uniQure sets $17 share price for $75 million offering By Investing.com - Investing.com Nigeria
uniQure (NASDAQ:QURE) Receives $33.88 Consensus Target Price from Brokerages - MarketBeat
uniQure (NASDAQ:QURE) Sees Strong Trading VolumeStill a Buy? - MarketBeat
uniQure sets $17 share price for $75 million offering - Investing.com India
uniQure Announces Pricing of its Public Offering - The Manila Times
uniQure Prices $75 Million Public Offering at $17.00 Per Share to Boost Growth Capital - StockTitan
uniQure Announces Proposed Public Offering - The Manila Times
uniQure Announces Public Offering of Ordinary Shares and Pre-Funded Warrants - StockTitan
UniQure stock soars to 52-week high, hits $18.5 amid robust gains - Investing.com Canada
uniQure (NASDAQ:QURE) Sets New 1-Year HighHere's What Happened - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):